Oregon

Synthetic Biology 2020: Frontiers in Risk Analysis and Governance by Benjamin D.

Description: Synthetic Biology 2020: Frontiers in Risk Analysis and Governance by Benjamin D. Trump, Christopher L. Cummings, Jennifer Kuzma, Igor Linkov Estimated delivery 3-12 business days Format Hardcover Condition Brand New Description Synthetic biology offers powerful remedies for some of the worlds most intractable problems, but these solutions are clouded by uncertainty and risk that few strategies are available to address. The incentives for continued development of this emerging technology are prodigious and obvious, and the public deserves assurances that all potential downsides are duly considered and minimized accordingly. Incorporating social science analysis within the innovation process may impose constraints, but its simultaneous support in making the end products more acceptable to society at large should be considered a worthy trade-off.Contributing authors in this volume represent diverse perspectives related to synthetic biologys social sciences, and reflect on different areas of risk analysis and governance that have developed for the field. Such perspectives include leading scholarly discussion pertaining to risk assessment, governance, ethics, and communication. The chapters of thisvolume note that while the first twenty years of synthetic biology development have focused strongly on technological innovation and product development, the next twenty should emphasize the synergy between developers, policymakers, and publics to generate the most beneficial, well governed, and transparent technologies and products possible. Many chapters in this volume provide new data and approaches that demonstrate the feasibility for multi-stakeholder efforts involving policymakers, regulators, industrial developers, workers, experts, and societal representatives to share responsibilities in the production of effective and acceptable governance in the face of uncertain risk probabilities. A full consideration of such perspectives may prevent a world of draconian regulations based on an insufficient or incomplete understanding of the science that underpins synthetic biology, as well as any hesitancy or fear by the public to adopt its eventual products. Author Biography Dr. Benjamin D. TRUMP is a Research Social Scientist for the US Army Engineer Research and Development Center. Dr. Trumps work focuses on decision making and governance of activities under significant uncertainty, such as emerging and enabling technologies (synthetic biology, nanotechnology) and developing organizational, infrastructural, social, and informational resilience against systemic threats to complex interconnected systems. Dr. Trump served as a delegate to assist US presence in OECDs Global Science Forum in 2017, and is the President of the Society for Risk Analysis Decision Analysis and Risk Specialty Group in 2018-2019. He was selected as a Fellow of the Emerging Leaders in Biosecurity Initiative (ELBI), Class of 2019. Dr. Trump was also a contributing author of the International Risk Governance Councils Guidelines for the Governance of Systemic Risks, as well as their 2nd Volume of the Resource Guide on Resilience. Dr. Trump is also frequently active with several Advanced Research Workshops for the North Atlantic Treaty Organizations Science for Peace Programme, including his role as a Program Committee Lead for a workshop on Biosecurity for Synthetic Biology and Emerging Biotechnologies. Dr. Trump received his Ph.D. from the University of Michigans School of Public Health, Department of Health Management and Policy in 2016. He received an M.S. (2012) in Public Policy and Management and a B.S. in Political Science (2011) from Carnegie Mellon University, and completed his postdoctoral training at the University of Lisbon, Portugal.Dr. Christopher L. CUMMINGS serves as an Assistant Professor of Strategic Communication at Nanyang Technological University, Singapore—a top ranked university in Asia and among the top 15 in the world. He is the Director of the International Strategic Communication Management program and has served in multiple leadership positions within the Society for Risk Analysis. Dr. Cummings work focuses on advancing public engagement with science, developing risk communication theory, and improving public health decision-making across the lifespan. An experienced social scientist and communication campaign scholar, Dr. Cummings uses a variety of quantitative, qualitative, and mixed-methods and his work has been featured in applied science and health venues including the Journal of Risk Research, Regulation and Governance, Nanotoxicology, PLOS One, Science, Technology & Human Values, and Climate Research among others. Outside of academia, Dr. Cummings also consults with multiple government agencies across Asia-Pacific on health risk communication issues including dengue fever surveillance and response (Sri Lanka and Singapore), obesity and nutrition access (New Zealand), vaccine communication (Singapore, Australia, and United States), and public engagement with nanotechnology, synthetic biology, and geoengineering (Australia, United States, and Singapore). He also consults privately with various Fortune 500 companies on leadership training, strategic planning, and risk communication initiatives. He completed his B.A. in Communication Studies (California State University, Chico), his M.S. in Communication and PhD in Communication, Rhetoric, and Digital Media (North Carolina State University), and his postdoctoral work under supervision of Dr. Jennifer Kuzma at the Genetic Engineering and Society Center (North Carolina State University).Dr. Jennifer KUZMA is the Goodnight-NC GSK Foundation Distinguished Professor in the School of Public and International Affairs, and co-founder and co-director of the Genetic Engineering and Society (GES) Center (research.ncsu.edu/ges), at NC State University. Prior to her current position, she was associate professor of at the Humphrey School of Public Affairs, University of Minnesota (2003-2013); study director for several NASEM reports related to biotechnology governance and bioterrorism (1999-2003); and an AAAS Risk Policy Fellow at the USDA (1997-1998). She has over 120 scholarly publications on emerging technologies, risk analysis, and governance including 4 articles in Science and Nature in the past 3 years. Kuzma served as a member of the WEF Global Futures Council on Technology, Values and Policy; the NASEM Committee on Preparing for Future Biotechnology; the FDA Blood Products Advisory Committee; and the UN WHO-FAO Expert Group for Agrifood Nanotechnologies; and as SRA Secretary and Council member. She currently serves on the AAAS-ABA National Council of Scientists and Lawyers. She received the SRA Sigma Xi Distinguished Lecturer Award for her contributions to the field of risk analysis; was elected a Fellow of AAAS in 2018 for distinguished work in anticipatory governance of new technologies; and was awarded the Fulbright Canada Visiting Research Chair in Science Policy in 2017. She appears frequently in the media for her expertise in biotechnology policy, including the New York Times, Science, Nature, NPR, Washington Post, Scientific American, PBS Nova, Wired, and ABC & NBC News. She obtained her Ph.D. in biochemistry from the U of CO Boulder in 1995 where she discovered bacterial isoprene production and was awarded the first patent for methods of bioisoprene production. Her postdoctoral work at the Rockefeller University on plant drought and salinity tolerance led to an article in the journal Science in 1997.Dr. Igor LINKOV is the Risk and Decision Science Focus Area Lead with the US Army Engineer Research and Development Center, and an Adjunct Professor with Carnegie Mellon University. Dr. Linkov has managed multiple risk and resilience assessments and management projects in many application domains, including cybersecurity, transportation, supply chain, homeland security and defense, and critical infrastructure. He was part of several Interagency Committees and Working Groups tasked withdeveloping resilience metrics and resilience management approaches, including the US Army Corps of Engineers Resilience Roadmap. Dr. Linkov has organized more than thirty national and international conferences and continuing education workshops, including NATO workshops on Cyber Resilience in Estonia (2018) and Finland (2019), as well as Chaired Program Committee for 2015 and 2019 World Congresses on Risk in Singapore and Cape Town. He has published widely on environmental policy, environmental modeling, and risk analysis, including twenty books and over 350 peer-reviewed papers and book chapters in top journals, like Nature, Nature Nanotechnology, Nature Climate Change, among others. He has served on many review and advisory panels for DOD, DHS, FDA, EPA, NSF, EU and other US and international agencies. Dr. Linkov is Society for Risk Analysis Fellow and recipient of 2005 Chauncey Starr Award for exceptional contribution to Risk Analysis as well as 2014 Outstanding Practitioner Award. He is an Elected Fellow with the American Association for the Advancement of Science (AAAS). Dr. Linkov has a B.S. and M.Sc. in Physics and Mathematics (Polytechnic Institute) and a Ph.D. in Environmental, Occupational and Radiation Health (University of Pittsburgh). He completed his postdoctoral training in Risk Assessment at Harvard University. Details ISBN 303027263X ISBN-13 9783030272630 Title Synthetic Biology 2020: Frontiers in Risk Analysis and Governance Author Benjamin D. Trump, Christopher L. Cummings, Jennifer Kuzma, Igor Linkov Format Hardcover Year 2019 Pages 421 Edition 1st Publisher Springer Nature Switzerland AG GE_Item_ID:137562755; About Us Grand Eagle Retail is the ideal place for all your shopping needs! With fast shipping, low prices, friendly service and over 1,000,000 in stock items - you're bound to find what you want, at a price you'll love! Shipping & Delivery Times Shipping is FREE to any address in USA. Please view eBay estimated delivery times at the top of the listing. Deliveries are made by either USPS or Courier. We are unable to deliver faster than stated. International deliveries will take 1-6 weeks. NOTE: We are unable to offer combined shipping for multiple items purchased. This is because our items are shipped from different locations. Returns If you wish to return an item, please consult our Returns Policy as below: Please contact Customer Services and request "Return Authorisation" before you send your item back to us. Unauthorised returns will not be accepted. Returns must be postmarked within 4 business days of authorisation and must be in resellable condition. Returns are shipped at the customer's risk. We cannot take responsibility for items which are lost or damaged in transit. For purchases where a shipping charge was paid, there will be no refund of the original shipping charge. Additional Questions If you have any questions please feel free to Contact Us. Categories Baby Books Electronics Fashion Games Health & Beauty Home, Garden & Pets Movies Music Sports & Outdoors Toys

Price: 221.18 USD

Location: Fairfield, Ohio

End Time: 2024-12-09T04:25:18.000Z

Shipping Cost: 0 USD

Product Images

Synthetic Biology 2020: Frontiers in Risk Analysis and Governance by Benjamin D.

Item Specifics

Restocking Fee: No

Return shipping will be paid by: Buyer

All returns accepted: Returns Accepted

Item must be returned within: 30 Days

Refund will be given as: Money Back

ISBN-13: 9783030272630

Type: NA

Publication Name: NA

Book Title: Synthetic Biology 2020: Frontiers in Risk Analysis and Governance

Number of Pages: Xxv, 421 Pages

Language: English

Publisher: Springer International Publishing A&G

Topic: Biotechnology, Chemical & Biochemical, Physics / General

Publication Year: 2019

Illustrator: Yes

Genre: Technology & Engineering, Science

Item Weight: 29.4 Oz

Item Length: 9.3 in

Author: Christopher Cummings

Item Width: 6.1 in

Book Series: Risk, Systems and Decisions Ser.

Format: Hardcover

Recommended

What Is Life?: Investigating the Nature of Life in the Age of Synthetic Biology
What Is Life?: Investigating the Nature of Life in the Age of Synthetic Biology

$6.50

View Details
Science News Magazine - January 12, 2013 - Life Remade Synthetic biology builds
Science News Magazine - January 12, 2013 - Life Remade Synthetic biology builds

$9.95

View Details
Synthetic Biology: A Primer by Paul S. Freemont; Richard I. Kitney
Synthetic Biology: A Primer by Paul S. Freemont; Richard I. Kitney

$17.37

View Details
A Systems Theoretic Approach to Systems and Synthetic Biology I & 2 Hardcover
A Systems Theoretic Approach to Systems and Synthetic Biology I & 2 Hardcover

$119.95

View Details
Nature Magazine November 24 2005 Synthetic Biology Global Warming
Nature Magazine November 24 2005 Synthetic Biology Global Warming

$8.99

View Details
SYNTHETIC BIOLOGY PROSPECTS: Prospects and Implications (2012)
SYNTHETIC BIOLOGY PROSPECTS: Prospects and Implications (2012)

$117.32

View Details
Synthetic Aesthetics Investigating Synthetic Biology's Designs on Nature VG
Synthetic Aesthetics Investigating Synthetic Biology's Designs on Nature VG

$32.99

View Details
Synthetic Biology: Safety, Security, and Promise by David R Franz: New
Synthetic Biology: Safety, Security, and Promise by David R Franz: New

$18.37

View Details
Synthetic Biology by Acron Massus
Synthetic Biology by Acron Massus

$77.40

View Details
Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves
Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves

$6.02

View Details